MFA-370
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MFA-370, covering 2024-09-26 to 2024-09-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MFA-370 in Patients with Metastatic Urothelial Cancer [Phase 1, Phase 2]